Tags: Chemical Compound, Chemical Substance.

Belinostat (PXD101) is experimental drug candidate under development by TopoTarget for the treatment of hematological malignancies and solid tumors. It is a histone deacetylase inhibitor.In 2007 preliminary results were released from the Phase II clinical trial of intravenous belinostat in combination with carboplatin and paclitaxel for relapsed ovarian cancer.

Belinostat.svg
IUPAC name
(2E)-N-Hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide

Loading...

This page contains content from the copyrighted Wikipedia article "Belinostat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.